186 related articles for article (PubMed ID: 14704816)
1. [Immunomodulation in penetrating keratoplasty. Current status and perspectives].
Pleyer U
Ophthalmologe; 2003 Dec; 100(12):1036-44. PubMed ID: 14704816
[TBL] [Abstract][Full Text] [Related]
2. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.
Lindenfeld J; Miller GG; Shakar SF; Zolty R; Lowes BD; Wolfel EE; Mestroni L; Page RL; Kobashigawa J
Circulation; 2004 Dec; 110(25):3858-65. PubMed ID: 15611389
[No Abstract] [Full Text] [Related]
3. Efficacy of postoperative immunosuppression after keratoplasty in herpetic keratitis.
Maier AK; Ozlügedik S; Rottler J; Heussen FM; Klamann MK; Huber KK; Joussen AM; Winterhalter S
Cornea; 2011 Dec; 30(12):1398-405. PubMed ID: 21996945
[TBL] [Abstract][Full Text] [Related]
4. [Evidences in immunosuppression in the maintenance of renal transplantation].
Hernández D; González-Posada JM
Nefrologia; 2005; 25(4):369-80. PubMed ID: 16231502
[No Abstract] [Full Text] [Related]
5. Balancing efficacy and toxicity in kidney-transplant immunosuppression.
Leichtman AB
N Engl J Med; 2007 Dec; 357(25):2625-7. PubMed ID: 18094383
[No Abstract] [Full Text] [Related]
6. Synergistic antiherpetic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease: first results of a randomised pilot study.
Mayer K; Reinhard T; Reis A; Voiculescu A; Sundmacher R
Graefes Arch Clin Exp Ophthalmol; 2003 Dec; 241(12):1051-4. PubMed ID: 12928902
[TBL] [Abstract][Full Text] [Related]
7. Optimizing the immunosuppressive regimen in heart transplantation.
Eisen H; Ross H
J Heart Lung Transplant; 2004 May; 23(5 Suppl):S207-13. PubMed ID: 15093807
[TBL] [Abstract][Full Text] [Related]
8. [Highly active antiviral and immunosuppressive combination therapy with acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease].
Reisr A; Reinhard T; Voiculescu A; Mayer K; Sundmacher R
Klin Monbl Augenheilkd; 2001 Mar; 218(3):183-6. PubMed ID: 11322055
[TBL] [Abstract][Full Text] [Related]
9. [Postoperative therapy after penetrating keratoplasty in herpes simplex keratitis].
Süveges I; Füst Á; Imre L
Orv Hetil; 2013 Dec; 154(52):2065-70. PubMed ID: 24374582
[TBL] [Abstract][Full Text] [Related]
10. Keratoplasty postoperative treatment update.
Shimmura-Tomita M; Shimmura S; Satake Y; Shimazaki-Den S; Omoto M; Tsubota K; Shimazaki J
Cornea; 2013 Nov; 32 Suppl 1():S60-4. PubMed ID: 24104936
[TBL] [Abstract][Full Text] [Related]
11. [Current practice of immune prophylaxis and therapy in perforating keratoplasty. A survey of members of the Cornea Section of the German Ophthalmological Society].
Bertelmann E; Reinhard T; Pleyer U
Ophthalmologe; 2003 Dec; 100(12):1031-5. PubMed ID: 14704815
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus and mycophenolate as combination prophylaxis in corneal transplant recipients at high rejection risk.
Chatel MA; Larkin DF
Am J Ophthalmol; 2010 Aug; 150(2):179-84. PubMed ID: 20570235
[TBL] [Abstract][Full Text] [Related]
13. Alemtuzumab preconditioning allows steroid-calcineurin inhibitor-free regimen in live-donor kidney transplant.
Refaie AF; Mahmoud KM; Ismail AM; Sheashaa HA; Kamal AI; Ghoneim MA
Exp Clin Transplant; 2011 Oct; 9(5):295-301. PubMed ID: 21967254
[TBL] [Abstract][Full Text] [Related]
14. High incidence of rejection episodes and poor tolerance of sirolimus in a protocol with early steroid withdrawal and calcineurin inhibitor-free maintenance therapy in renal transplantation: experiences of a randomized prospective single-center study.
Burkhalter F; Oettl T; Descoeudres B; Bachmann A; Guerke L; Mihatsch MJ; Dickenmann M; Steiger J
Transplant Proc; 2012 Dec; 44(10):2961-5. PubMed ID: 23195006
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus use in de "novo renal" transplantation.
Grinyo JM; Alonso A; Arias M; Campistol JM; González Molina M; González Posada JM; Morales JM; Oppenheimer F; Sánchez Fructuoso A; Sánchez-Plumed J; Ruiz JC
Nefrologia; 2006; 26 Suppl 2():33-51. PubMed ID: 17937633
[No Abstract] [Full Text] [Related]
16. Pulmonary toxicity associated with sirolimus following kidney transplantation: computed tomography findings.
Davaus Gasparetto T; Marchiori E; Menezes P; Zanetti G
Nefrologia; 2010; 30(2):259-60. PubMed ID: 20393625
[No Abstract] [Full Text] [Related]
17. [Immunossupresive drugs in renal transplantation].
Baczkowska T; Durlik M
Pol Arch Med Wewn; 2004 Oct; 112 Spec No():99-120. PubMed ID: 15669207
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
19. De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis.
Zucker MJ; Baran DA; Arroyo LH; Goldstein DJ; Neacy C; Mele L; Weinberg AD; Prendergast TW; Ribner HS
Transplant Proc; 2005 Jun; 37(5):2231-9. PubMed ID: 15964386
[TBL] [Abstract][Full Text] [Related]
20. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus.
Hunt SA
Cardiol Rev; 2000; 8(3):180-4. PubMed ID: 11174892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]